What you'll learn
- Describe an overview and highlight the recent medical advances present at the Annual Meeting of the American Society of Hematologists (ASH) which will help physicians achieve better patient outcomes.
- Recognize appropriate management and treatment options for hematologic malignancies.
- Utilize these approaches in routine clinical practice.
- Review new therapies and approaches in non-malignant hematology.
The American Society of Hematology’s annual meeting in December is the venue at which cutting edge therapeutic advances are presented publicly for the first time. Unfortunately, only a small fraction of practitioners can attend this meeting. It is therefore of vital importance for practitioners and, in turn, their patients to have access to emerging data in a timely fashion. At this one-day activity, attendees will receive relevant updates on advances in acute leukemia, myelodysplasia, myeloproliferative disorders, chronic myelogenous leukemia, chronic lymphocytic leukemia, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, multiple myeloma, Waldenstrom’s macroglobulinemia, coagulation disorders, hematopoietic stem cell transplantation and CAR-T therapies.
This accredited course is offered by Dana Farber Cancer Institute This course is targeted to Primary Care Physicians, Specialty Physicians, Nurses, Nurse Practitioners, Physicians Assistants, Oncology and Hematology. Contact firstname.lastname@example.org with questions.
You may also like
- OnlineAn in-depth look at the 1854 London cholera epidemic in Soho and its importance for the field of epidemiology.